3 Small Biotech Stocks in Focus on World Arthritis Day
Every year World Arthritis Day is observed on Oct 12 to raise awareness on the disease’s far-reaching impact on patients across the globe. On this day, several arthritis-related groups including the Arthritis Foundation and European more...
Celsion Corporation Announces Oral Presentation at International Vaccines Congress
Chief Science Officer Dr. Khursheed Anwer to D eliver V irtual P resentation on Celsion’s O ngoing W ork with DNA-based V accines LAWRENCEVILLE, N.J., Oct. 12, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), more...
AGTC to Present at Upcoming Cell & Gene Management Meeting on the Mesa
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare inherited retinal more...
Abeona Therapeutics Appoints Gene Therapy Quality Leader Jon Voss as Vice President, Head of Quality
NEW YORK and CLEVELAND, Oct. 12, 2021 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Jon Voss as Vice President, Head of more...
Fortress’ (FBIO) Partner Meets Study Goal for Menkes Disease
Fortress Biotech FBIO along with its partner company Cyprium Therapeutics announced that the two completed pivotal studies evaluating CUTX-101, its candidate for the treatment of patients with Menkes disease, achieved both primary and secondary efficacy more...
Celsion GmbH Announces the Publication of an Article Reviewing the History of ThermoDox® Drug Development in Advanced Drug Delivery Reviews
Investigator-Sponsored Research with ThermoDox ® Continues in Multiple Indications New Support for ThermoDox ® ’s P otential from the National Institutes of Health under a Cooperative Research and Development Agreement ZUG, Switzerland, Oct. 11, 2021 more...
Do Options Traders Know Something About aTyr Pharma (LIFE) Stock We Don’t?
Investors in aTyr Pharma, Inc. LIFE need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 19, 2021 $12.50 Call had some of the more...
CNS Pharmaceuticals Inc. Featured in Syndicated Broadcast Covering Dosing of First Patients in Its Berubicin Clinical Development Program for Glioblastoma Multiforme
LOS ANGELES, Oct. 11, 2021 (GLOBE NEWSWIRE) — via InvestorWire — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) , a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain more...
aTyr Pharma to Participate in Piper Sandler Investor Lung Day
SAN DIEGO, Oct. 11, 2021 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways, today announced that Sanjay S. more...
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity
SHELTON, CT / ACCESSWIRE / October 11, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines technology, announced today that its more...